Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Change In Inventory : $-0.67 Mil (TTM As of Dec. 2018)

View and export this data going back to 2014. Start your Free Trial

What is Parnell Pharmaceuticals Holdings Change In Inventory?

Parnell Pharmaceuticals Holdings's change in inventory for the quarter that ended in Dec. 2018 was $-0.67 Mil. It means Parnell Pharmaceuticals Holdings's inventory increased by $0.67 Mil from Dec. 2017 to Dec. 2018 .

Parnell Pharmaceuticals Holdings's change in inventory for the fiscal year that ended in Dec. 2018 was $-0.67 Mil. It means Parnell Pharmaceuticals Holdings's inventory increased by $0.67 Mil from Dec. 2017 to Dec. 2018 .

Parnell Pharmaceuticals Holdings's Total Inventories for the quarter that ended in Dec. 2018 was $2.29 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Parnell Pharmaceuticals Holdings's Days Inventory for the quarter that ended in Dec. 2018 was 45.30.

Inventory Turnover measures how fast the company turns over its inventory within a year. Parnell Pharmaceuticals Holdings's Inventory Turnover for the quarter that ended in Dec. 2018 was 4.03.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Parnell Pharmaceuticals Holdings's Inventory-to-Revenue for the quarter that ended in Dec. 2018 was 0.10.

Parnell Pharmaceuticals Holdings Change In Inventory Historical Data

The historical data trend for Parnell Pharmaceuticals Holdings's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parnell Pharmaceuticals Holdings Change In Inventory Chart

Parnell Pharmaceuticals Holdings Annual Data

Trend

Jun12

Jun13

Jun14

Dec15

Dec16

Dec17

Dec18

Change In Inventory

Get a 7-Day Free Trial

-0.10

-0.49

-0.14

1.04

-0.67

Parnell Pharmaceuticals Holdings Semi-Annual Data
	Jun12	Jun13	Jun14	Dec15	Dec16	Dec17	Dec18
Change In Inventory	Get a 7-Day Free Trial			-0.10	-0.49	-0.14	1.04	-0.67

Parnell Pharmaceuticals Holdings Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2018 was $-0.67 Mil.

Parnell Pharmaceuticals Holdings (OTCPK:PARNF) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Parnell Pharmaceuticals Holdings's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	1.9615	/	7.903	*	365 / 2
	=	45.30

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Parnell Pharmaceuticals Holdings's Inventory Turnover for the quarter that ended in Dec. 2018 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	7.903	/	1.9615
	=	4.03

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Parnell Pharmaceuticals Holdings's Inventory to Revenue for the quarter that ended in Dec. 2018 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	1.9615	/	19.031
	=	0.10

Parnell Pharmaceuticals Holdings Change In Inventory Related Terms

Thank you for viewing the detailed overview of Parnell Pharmaceuticals Holdings's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARNF) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

476 Gardeners Road, Unit 4, Century Estate, Alexandria, Sydney, NSW, AUS, 2015

Website

https://www.parnell.com

Parnell Pharmaceuticals Holdings Ltd is an Australia based veterinary pharmaceutical company. It is focused on developing, manufacturing and commercializing animal health solutions. The group manufactures and market products for companion animals and production animals. The firm also has a pipeline of drug products like Zydax, PAR121 and PAR122 and Luminous which covers therapeutic areas in orthopedics, dermatology, and nutraceuticals. The operating segments of the company are Companion animal, Production animal - U.S., Production animal - rest of world and Contract Manufacturing. It operates internationally and generates the majority of the revenue from the Production animal - U.S. segment which covers the group's reproductive hormone portfolio across production animal in the USA.